ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. J Am Coll Radiol 2016 Mar;13(3):265-73
Date
03/06/2016Pubmed ID
26944037DOI
10.1016/j.jacr.2015.12.001Scopus ID
2-s2.0-84959354982 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Management of primary and secondary hepatic malignancy is a complex problem. Achieving optimal care for this challenging population often requires the involvement of multiple medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and loco-regional therapies, such as thermal ablation and transarterial embolization techniques. This article provides a review of treatment strategies for the three most common subtypes of hepatic malignancy treated with loco-regional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Author List
Kouri BE, Abrams RA, Al-Refaie WB, Azad N, Farrell J, Gaba RC, Gervais DA, Gipson MG, Kolbeck KJ, Marshalleck FE, Pinchot JW, Small W Jr, Ray CE Jr, Hohenwalter EJAuthor
Eric J. Hohenwalter MD, FSIR Chief, Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Chemoembolization, TherapeuticChemoradiotherapy
Evidence-Based Medicine
Humans
Liver Neoplasms
Practice Guidelines as Topic
Radiology
Societies, Medical
Treatment Outcome
United States









